We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA, Roche Warn on Fake Avastin Entering U.S. Via Foreign Supplier
FDA, Roche Warn on Fake Avastin Entering U.S. Via Foreign Supplier
March 1, 2012
Counterfeit versions of Genentech’s cancer drug Avastin are circulating in the U.S. supply chain after 19 practitioners bought the drug from an unauthorized foreign supplier, the FDA and the Swiss-owned drugmaker warn.